메뉴 건너뛰기




Volumn 39, Issue 5, 2011, Pages 1183-1192

miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression

Author keywords

Androgen; Biochemical relapse; microRNA; Prognostic marker; Prostate cancer; Prostate cancer relapse; Prostate specific antigen; Tumor marker

Indexed keywords

FORMALDEHYDE; MICRORNA; PARAFFIN;

EID: 80053216927     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1128     Document Type: Article
Times cited : (61)

References (65)
  • 1
    • 0033935812 scopus 로고    scopus 로고
    • Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued risk of biochemical failure after 5 years
    • Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J and Zincke H: Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 164: 101-105, 2000. (Pubitemid 30434268)
    • (2000) Journal of Urology , vol.164 , Issue.1 , pp. 101-105
    • Amling, C.L.1    Blute, M.L.2    Bergstralh, E.J.3    Seay, T.M.4    Slezak, J.5    Zincke, H.6
  • 2
    • 0037304517 scopus 로고    scopus 로고
    • Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
    • DOI 10.1016/S0022-5347(05)63946-8
    • Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI and Walsh PC: Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169: 517-523, 2003. (Pubitemid 36132976)
    • (2003) Journal of Urology , vol.169 , Issue.2 , pp. 517-523
    • Han, M.1    Partin, A.W.2    Zahurak, M.3    Piantadosi, S.4    Epstein, J.I.5    Walsh, P.C.6
  • 3
    • 0032702052 scopus 로고    scopus 로고
    • Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results
    • DOI 10.1016/S0090-4295(99)00252-6, PII S0090429599002526
    • Jhaveri FM, Zippe CD, Klein EA and Kupelian PA: Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 54: 884-890, 1999. (Pubitemid 29505591)
    • (1999) Urology , vol.54 , Issue.5 , pp. 884-890
    • Jhaveri, F.M.1    Zippe, C.D.2    Klein, E.A.3    Kupelian, P.A.4
  • 4
    • 77957579281 scopus 로고    scopus 로고
    • Predictive and prognostic models in radical prostatectomy candidates: A critical analysis of the literature
    • Lughezzani G, Briganti A, Karakiewicz PI, et al: Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol 58: 687-700, 2010.
    • (2010) Eur Urol , vol.58 , pp. 687-700
    • Lughezzani, G.1    Briganti, A.2    Karakiewicz, P.I.3
  • 5
    • 68849085858 scopus 로고    scopus 로고
    • Models for prevention and treatment of cancer: Problems vs promises
    • Aggarwal BB, Danda D, Gupta S and Gehlot P: Models for prevention and treatment of cancer: problems vs promises. Biochem Pharmacol 78: 1083-1094, 2009.
    • (2009) Biochem Pharmacol , vol.78 , pp. 1083-1094
    • Aggarwal, B.B.1    Danda, D.2    Gupta, S.3    Gehlot, P.4
  • 6
    • 64949201827 scopus 로고    scopus 로고
    • From bench to bedside: Current and future applications of molecular profiling in renal cell carcinoma
    • Arsanious A, Bjarnason GA and Yousef GM: From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Mol Cancer 8: 20, 2009.
    • (2009) Mol Cancer , vol.8 , pp. 20
    • Arsanious, A.1    Bjarnason, G.A.2    Yousef, G.M.3
  • 7
    • 11844262661 scopus 로고    scopus 로고
    • Phylogenetic shadowing and computational identification of human microRNA genes
    • DOI 10.1016/j.cell.2004.12.031, PII S0092867404012565
    • Berezikov E, Guryev V, Van de Belt J, Wienholds E, Plasterk RH and Cuppen E: Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24, 2005. (Pubitemid 40094599)
    • (2005) Cell , vol.120 , Issue.1 , pp. 21-24
    • Berezikov, E.1    Guryev, V.2    Van De, B.J.3    Wienholds, E.4    Plasterk, R.H.A.5    Cuppen, E.6
  • 8
    • 38349169664 scopus 로고    scopus 로고
    • Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?
    • Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
    • (2008) Nat Rev Genet , vol.9 , pp. 102-114
    • Filipowicz, W.1    Bhattacharyya, S.N.2    Sonenberg, N.3
  • 9
    • 70349098023 scopus 로고    scopus 로고
    • MicroRNAs in clinical oncology: At the crossroads between promises and problems
    • Metias SM, Lianidou E and Yousef GM: MicroRNAs in clinical oncology: at the crossroads between promises and problems. J Clin Pathol 62: 771-776, 2009.
    • (2009) J Clin Pathol , vol.62 , pp. 771-776
    • Metias, S.M.1    Lianidou, E.2    Yousef, G.M.3
  • 10
    • 72649084669 scopus 로고    scopus 로고
    • Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis
    • Chow TF, Youssef YM, Lianidou E, et al: Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43: 150-158, 2010.
    • (2010) Clin Biochem , vol.43 , pp. 150-158
    • Chow, T.F.1    Youssef, Y.M.2    Lianidou, E.3
  • 11
    • 70350755290 scopus 로고    scopus 로고
    • MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
    • Jung M, Mollenkopf HJ, Grimm C, et al: MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928, 2009.
    • (2009) J Cell Mol Med , vol.13 , pp. 3918-3928
    • Jung, M.1    Mollenkopf, H.J.2    Grimm, C.3
  • 13
    • 51049123624 scopus 로고    scopus 로고
    • Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer
    • Ambs S, Prueitt RL, Yi M, et al: Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68: 6162-6170, 2008.
    • (2008) Cancer Res , vol.68 , pp. 6162-6170
    • Ambs, S.1    Prueitt, R.L.2    Yi, M.3
  • 14
    • 40749090479 scopus 로고    scopus 로고
    • Widespread deregulation of microRNA expression in human prostate cancer
    • DOI 10.1038/sj.onc.1210809, PII 1210809
    • Ozen M, Creighton CJ, Ozdemir M and Ittmann M: Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793, 2008. (Pubitemid 351380263)
    • (2008) Oncogene , vol.27 , Issue.12 , pp. 1788-1793
    • Ozen, M.1    Creighton, C.J.2    Ozdemir, M.3    Ittmann, M.4
  • 16
    • 74049163692 scopus 로고    scopus 로고
    • Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
    • Schaefer A, Jung M, Mollenkopf HJ, et al: Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176, 2010.
    • (2010) Int J Cancer , vol.126 , pp. 1166-1176
    • Schaefer, A.1    Jung, M.2    Mollenkopf, H.J.3
  • 17
    • 77953723274 scopus 로고    scopus 로고
    • Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence
    • Spahn M, Kneitz S, Scholz CJ, et al: Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 127: 394-403, 2010.
    • (2010) Int J Cancer , vol.127 , pp. 394-403
    • Spahn, M.1    Kneitz, S.2    Scholz, C.J.3
  • 18
    • 60149087720 scopus 로고    scopus 로고
    • MicroRNA profile analysis of human prostate cancers
    • Tong AW, Fulgham P, Jay C, et al: MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 16: 206-216, 2009.
    • (2009) Cancer Gene Ther , vol.16 , pp. 206-216
    • Tong, A.W.1    Fulgham, P.2    Jay, C.3
  • 20
    • 40449131878 scopus 로고    scopus 로고
    • Loss of mir-146a function in hormone-refractory prostate cancer
    • DOI 10.1261/rna.874808
    • Lin SL, Chiang A, Chang D and Ying SY: Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14: 417-424, 2008. (Pubitemid 351397806)
    • (2008) RNA , vol.14 , Issue.3 , pp. 417-424
    • Lin, S.-L.1    Chiang, A.2    Chang, D.3    Ying, S.-Y.4
  • 21
    • 48749099913 scopus 로고    scopus 로고
    • Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer
    • Prueitt RL, Yi M, Hudson RS, et al: Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68: 1152-1164, 2008.
    • (2008) Prostate , vol.68 , pp. 1152-1164
    • Prueitt, R.L.1    Yi, M.2    Hudson, R.S.3
  • 22
    • 79955721096 scopus 로고    scopus 로고
    • Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis
    • Leite KR, Sousa-Canavez JM, Reis ST, et al: Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol 29: 265-269, 2011.
    • (2011) Urol Oncol , vol.29 , pp. 265-269
    • Leite, K.R.1    Sousa-Canavez, J.M.2    Reis, S.T.3
  • 23
    • 77952292124 scopus 로고    scopus 로고
    • Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors
    • Schaefer A, Stephan C, Busch J, Yousef GM and Jung K: Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7: 286-297, 2010.
    • (2010) Nat Rev Urol , vol.7 , pp. 286-297
    • Schaefer, A.1    Stephan, C.2    Busch, J.3    Yousef, G.M.4    Jung, K.5
  • 24
    • 57649207038 scopus 로고    scopus 로고
    • Expression profiling with RNA from formalin-fixed, paraffin-embedded material
    • Oberli A, Popovici V, Delorenzi M, et al: Expression profiling with RNA from formalin-fixed, paraffin-embedded material. BMC Med Genomics 1: 9, 2008.
    • (2008) BMC Med Genomics , vol.1 , pp. 9
    • Oberli, A.1    Popovici, V.2    Delorenzi, M.3
  • 25
    • 67650504966 scopus 로고    scopus 로고
    • TScratch: A novel and simple software tool for automated analysis of monolayer wound healing assays
    • Geback T, Schulz MM, Koumoutsakos P and Detmar M: TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46: 265-274, 2009.
    • (2009) Biotechniques , vol.46 , pp. 265-274
    • Geback, T.1    Schulz, M.M.2    Koumoutsakos, P.3    Detmar, M.4
  • 26
    • 77950516941 scopus 로고    scopus 로고
    • Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through down-regulating RhoGDIA
    • Ding J, Huang S, Wu S, et al: Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through down-regulating RhoGDIA. Nat Cell Biol 12: 390-399, 2010.
    • (2010) Nat Cell Biol , vol.12 , pp. 390-399
    • Ding, J.1    Huang, S.2    Wu, S.3
  • 27
    • 76749102887 scopus 로고    scopus 로고
    • E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis
    • Lize M, Pilarski S and Dobbelstein M: E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 17: 452-458, 2010.
    • (2010) Cell Death Differ , vol.17 , pp. 452-458
    • Lize, M.1    Pilarski, S.2    Dobbelstein, M.3
  • 28
    • 39849097124 scopus 로고    scopus 로고
    • Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells
    • Musiyenko A, Bitko V and Barik S: Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med 86: 313-322, 2008.
    • (2008) J Mol Med , vol.86 , pp. 313-322
    • Musiyenko, A.1    Bitko, V.2    Barik, S.3
  • 29
    • 58549108465 scopus 로고    scopus 로고
    • Epigenetic therapy up-regulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells
    • Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC and Liang G: Epigenetic therapy up-regulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379: 726-731, 2009.
    • (2009) Biochem Biophys Res Commun , vol.379 , pp. 726-731
    • Saito, Y.1    Friedman, J.M.2    Chihara, Y.3    Egger, G.4    Chuang, J.C.5    Liang, G.6
  • 30
    • 77957821737 scopus 로고    scopus 로고
    • Expression of miR-196b is not exclusively MLL-driven but especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia
    • Schotte D, Lange-Turenhout EA, Stumpel DJ, et al: Expression of miR-196b is not exclusively MLL-driven but especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica 95: 1675-1682, 2010.
    • (2010) Haematologica , vol.95 , pp. 1675-1682
    • Schotte, D.1    Lange-Turenhout, E.A.2    Stumpel, D.J.3
  • 33
    • 0036736248 scopus 로고    scopus 로고
    • Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses
    • Macabeo-Ong M, Ginzinger DG, Dekker N, et al: Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. Mod Pathol 15: 979-987, 2002.
    • (2002) Mod Pathol , vol.15 , pp. 979-987
    • Macabeo-Ong, M.1    Ginzinger, D.G.2    Dekker, N.3
  • 34
    • 77952962186 scopus 로고    scopus 로고
    • Robust microRNA stability in degraded RNA preparations from human tissue and cell samples
    • Jung M, Schaefer A, Steiner I, et al: Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 56: 998-1006, 2010.
    • (2010) Clin Chem , vol.56 , pp. 998-1006
    • Jung, M.1    Schaefer, A.2    Steiner, I.3
  • 35
    • 58049157656 scopus 로고    scopus 로고
    • Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology
    • Hasemeier B, Christgen M, Kreipe H and Lehmann U: Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology. BMC Biotechnol 8: 90, 2008.
    • (2008) BMC Biotechnol , vol.8 , pp. 90
    • Hasemeier, B.1    Christgen, M.2    Kreipe, H.3    Lehmann, U.4
  • 36
    • 51349103144 scopus 로고    scopus 로고
    • Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
    • Foekens JA, Sieuwerts AM, Smid M, et al: Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 105: 13021-13026, 2008.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 13021-13026
    • Foekens, J.A.1    Sieuwerts, A.M.2    Smid, M.3
  • 37
    • 76749142479 scopus 로고    scopus 로고
    • A microRNA expression signature for cervical cancer prognosis
    • Hu X, Schwarz JK, Lewis JS Jr, et al: A microRNA expression signature for cervical cancer prognosis. Cancer Res 70: 1441-1448, 2010.
    • (2010) Cancer Res , vol.70 , pp. 1441-1448
    • Hu, X.1    Schwarz, J.K.2    Lewis Jr., J.S.3
  • 38
    • 77951748235 scopus 로고    scopus 로고
    • Survival prediction of gastric cancer by a seven-microRNA signature
    • Li X, Zhang Y, Ding J, Wu K and Fan D: Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59: 579-585, 2010.
    • (2010) Gut , vol.59 , pp. 579-585
    • Li, X.1    Zhang, Y.2    Ding, J.3    Wu, K.4    Fan, D.5
  • 39
    • 50849137458 scopus 로고    scopus 로고
    • MicroRNA expression profiles in serous ovarian carcinoma
    • Nam EJ, Yoon H, Kim SW, et al: MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695, 2008.
    • (2008) Clin Cancer Res , vol.14 , pp. 2690-2695
    • Nam, E.J.1    Yoon, H.2    Kim, S.W.3
  • 40
    • 77950498821 scopus 로고    scopus 로고
    • Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small cell lung cancer
    • Hu Z, Chen X, Zhao Y, et al: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small cell lung cancer. J Clin Oncol 28: 1721-1726, 2010.
    • (2010) J Clin Oncol , vol.28 , pp. 1721-1726
    • Hu, Z.1    Chen, X.2    Zhao, Y.3
  • 41
    • 70349662168 scopus 로고    scopus 로고
    • MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: Associations with survival
    • Mathe EA, Nguyen GH, Bowman ED, et al: MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15: 6192-6200, 2009.
    • (2009) Clin Cancer Res , vol.15 , pp. 6192-6200
    • Mathe, E.A.1    Nguyen, G.H.2    Bowman, E.D.3
  • 42
    • 70449571904 scopus 로고    scopus 로고
    • miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice
    • Clape C, Fritz V, Henriquet C, et al: miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 4: e7542, 2009.
    • (2009) PLoS One , vol.4
    • Clape, C.1    Fritz, V.2    Henriquet, C.3
  • 43
    • 39049128249 scopus 로고    scopus 로고
    • Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
    • DOI 10.1159/000113489
    • Slaby O, Svoboda M, Fabian P, et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007. (Pubitemid 351238155)
    • (2007) Oncology , vol.72 , Issue.5-6 , pp. 397-402
    • Slaby, O.1    Svoboda, M.2    Fabian, P.3    Smerdova, T.4    Knoflickova, D.5    Bednarikova, M.6    Nenutil, R.7    Vyzula, R.8
  • 44
    • 70449713652 scopus 로고    scopus 로고
    • Karyotype-specific microRNA signature in chronic lymphocytic leukemia
    • Visone R, Rassenti LZ, Veronese A, et al: Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 114: 3872-3879, 2009.
    • (2009) Blood , vol.114 , pp. 3872-3879
    • Visone, R.1    Rassenti, L.Z.2    Veronese, A.3
  • 45
    • 73449134501 scopus 로고    scopus 로고
    • Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
    • Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P and Taubert H: Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126: 73-80, 2010.
    • (2010) Int J Cancer , vol.126 , pp. 73-80
    • Greither, T.1    Grochola, L.F.2    Udelnow, A.3    Lautenschlager, C.4    Wurl, P.5    Taubert, H.6
  • 46
    • 61349141809 scopus 로고    scopus 로고
    • Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer
    • Wang CJ, Zhou ZG, Wang L, et al: Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 26: 27-34, 2009.
    • (2009) Dis Markers , vol.26 , pp. 27-34
    • Wang, C.J.1    Zhou, Z.G.2    Wang, L.3
  • 47
    • 70449500709 scopus 로고    scopus 로고
    • Regulation of JAK2 by miR-135a: Prognostic impact in classic Hodgkin lymphoma
    • Navarro A, Diaz T, Martinez A, et al: Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood 114: 2945-2951, 2009.
    • (2009) Blood , vol.114 , pp. 2945-2951
    • Navarro, A.1    Diaz, T.2    Martinez, A.3
  • 48
    • 66349104794 scopus 로고    scopus 로고
    • Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro
    • Dyrskjot L, Ostenfeld MS, Bramsen JB, et al: Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860, 2009.
    • (2009) Cancer Res , vol.69 , pp. 4851-4860
    • Dyrskjot, L.1    Ostenfeld, M.S.2    Bramsen, J.B.3
  • 49
    • 77951162117 scopus 로고    scopus 로고
    • The microRNA profile of prostate carcinoma obtained by deep sequencing
    • Szczyrba J, Loprich E, Wach S, et al: The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 8: 529-538, 2010.
    • (2010) Mol Cancer Res , vol.8 , pp. 529-538
    • Szczyrba, J.1    Loprich, E.2    Wach, S.3
  • 50
    • 79959240667 scopus 로고    scopus 로고
    • MicroRNA profiles of prostate carcinoma detected by multi-platform miRNA screening
    • March 11, Epub ahead of print
    • Wach S, Nolte E, Szczyrba J, et al: MicroRNA profiles of prostate carcinoma detected by multi-platform miRNA screening. Int J Cancer: March 11, 2011 (Epub ahead of print).
    • (2011) Int J Cancer
    • Wach, S.1    Nolte, E.2    Szczyrba, J.3
  • 51
    • 35148886434 scopus 로고    scopus 로고
    • Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
    • DOI 10.1038/nature06174, PII NATURE06174
    • Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688, 2007. (Pubitemid 47552092)
    • (2007) Nature , vol.449 , Issue.7163 , pp. 682-688
    • Ma, L.1    Teruya-Feldstein, J.2    Weinberg, R.A.3
  • 52
    • 68249139817 scopus 로고    scopus 로고
    • MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC
    • Sasayama T, Nishihara M, Kondoh T, Hosoda K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 125: 1407-1413, 2009.
    • (2009) Int J Cancer , vol.125 , pp. 1407-1413
    • Sasayama, T.1    Nishihara, M.2    Kondoh, T.3    Hosoda, K.4    Kohmura, E.5
  • 53
    • 46249083024 scopus 로고    scopus 로고
    • MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
    • DOI 10.1002/hep.22256
    • Ladeiro Y, Couchy G, Balabaud C, et al: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963, 2008. (Pubitemid 351952843)
    • (2008) Hepatology , vol.47 , Issue.6 , pp. 1955-1963
    • Ladeiro, Y.1    Couchy, G.2    Balabaud, C.3    Bioulac-Sage, P.4    Pelletier, L.5    Rebouissou, S.6    Zucman-Rossi, J.7
  • 54
    • 70349134366 scopus 로고    scopus 로고
    • MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
    • Baffa R, Fassan M, Volinia S, et al: MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219: 214-221, 2009.
    • (2009) J Pathol , vol.219 , pp. 214-221
    • Baffa, R.1    Fassan, M.2    Volinia, S.3
  • 55
    • 77953213140 scopus 로고    scopus 로고
    • MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival
    • Wurz K, Garcia RL, Goff BA, et al: MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer 49: 577-584, 2010.
    • (2010) Genes Chromosomes Cancer , vol.49 , pp. 577-584
    • Wurz, K.1    Garcia, R.L.2    Goff, B.A.3
  • 56
    • 63449123568 scopus 로고    scopus 로고
    • MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31
    • Veerla S, Lindgren D, Kvist A, et al: MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 124: 2236-2242, 2009.
    • (2009) Int J Cancer , vol.124 , pp. 2236-2242
    • Veerla, S.1    Lindgren, D.2    Kvist, A.3
  • 57
    • 77950877531 scopus 로고    scopus 로고
    • MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines
    • Tian Y, Luo A, Cai Y, et al: MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 285: 7986-7994, 2010.
    • (2010) J Biol Chem , vol.285 , pp. 7986-7994
    • Tian, Y.1    Luo, A.2    Cai, Y.3
  • 58
    • 77955956247 scopus 로고    scopus 로고
    • MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1
    • Chai G, Liu N, Ma J, et al: MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 101: 1997-2004, 2010.
    • (2010) Cancer Sci , vol.101 , pp. 1997-2004
    • Chai, G.1    Liu, N.2    Ma, J.3
  • 59
    • 77950665077 scopus 로고    scopus 로고
    • Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
    • Ma L, Reinhardt F, Pan E, et al: Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347, 2010.
    • (2010) Nat Biotechnol , vol.28 , pp. 341-347
    • Ma, L.1    Reinhardt, F.2    Pan, E.3
  • 60
    • 34247648712 scopus 로고    scopus 로고
    • MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis
    • DOI 10.1038/sj.leu.2404605, PII 2404605
    • Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A and Young BD: MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21: 912-916, 2007. (Pubitemid 46672066)
    • (2007) Leukemia , vol.21 , Issue.5 , pp. 912-916
    • Debernardi, S.1    Skoulakis, S.2    Molloy, G.3    Chaplin, T.4    Dixon-McIver, A.5    Young, B.D.6
  • 61
    • 78449234396 scopus 로고    scopus 로고
    • Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion
    • Bourguignon LY, Wong G, Earle C, Krueger K and Spevak CC: Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem 285: 36721-36735, 2010.
    • (2010) J Biol Chem , vol.285 , pp. 36721-36735
    • Bourguignon, L.Y.1    Wong, G.2    Earle, C.3    Krueger, K.4    Spevak, C.C.5
  • 62
    • 66049148777 scopus 로고    scopus 로고
    • The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines
    • Sun T, Wang Q, Balk S, Brown M, Lee GS and Kantoff P: The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 69: 3356-3363, 2009.
    • (2009) Cancer Res , vol.69 , pp. 3356-3363
    • Sun, T.1    Wang, Q.2    Balk, S.3    Brown, M.4    Lee, G.S.5    Kantoff, P.6
  • 63
    • 79954987841 scopus 로고    scopus 로고
    • NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells
    • Jan 18, Epub ahead of print
    • Galardi S, Mercatelli N, Farace MG and Ciafre SA: NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res: Jan 18, 2011 (Epub ahead of print).
    • (2011) Nucleic Acids Res
    • Galardi, S.1    Mercatelli, N.2    Farace, M.G.3    Ciafre, S.A.4
  • 64
    • 58149240996 scopus 로고    scopus 로고
    • The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice
    • Mercatelli N, Coppola V, Bonci D, et al: The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One 3: e4029, 2008.
    • (2008) PLoS One , vol.3
    • Mercatelli, N.1    Coppola, V.2    Bonci, D.3
  • 65
    • 79851508659 scopus 로고    scopus 로고
    • MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer
    • Leite KR, Tomiyama A, Reis ST, et al: MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J Urol 185: 1118-1122, 2011.
    • (2011) J Urol , vol.185 , pp. 1118-1122
    • Leite, K.R.1    Tomiyama, A.2    Reis, S.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.